BR9710376A - Composto antiviral uso do mesmo composi-Æo farmac-utica e processo para tratamento antiviral profil tico ou terap-utico de um animal humano ou nÆo humano - Google Patents
Composto antiviral uso do mesmo composi-Æo farmac-utica e processo para tratamento antiviral profil tico ou terap-utico de um animal humano ou nÆo humanoInfo
- Publication number
- BR9710376A BR9710376A BR9710376A BR9710376A BR9710376A BR 9710376 A BR9710376 A BR 9710376A BR 9710376 A BR9710376 A BR 9710376A BR 9710376 A BR9710376 A BR 9710376A BR 9710376 A BR9710376 A BR 9710376A
- Authority
- BR
- Brazil
- Prior art keywords
- human
- prophylactic
- antiviral
- pharmaceutical composition
- same pharmaceutical
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/36—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino acids, polyamines and polycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
- C08G69/10—Alpha-amino-carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO1043A AUPO104396A0 (en) | 1996-07-17 | 1996-07-17 | Antiviral linear polymers |
PCT/AU1997/000446 WO1998003572A1 (en) | 1996-07-17 | 1997-07-17 | Antiviral linear polymers |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9710376A true BR9710376A (pt) | 1999-08-17 |
Family
ID=3795359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9710376A BR9710376A (pt) | 1996-07-17 | 1997-07-17 | Composto antiviral uso do mesmo composi-Æo farmac-utica e processo para tratamento antiviral profil tico ou terap-utico de um animal humano ou nÆo humano |
Country Status (10)
Country | Link |
---|---|
US (1) | US6740635B2 (pt) |
EP (1) | EP0928306A4 (pt) |
JP (1) | JP2000516971A (pt) |
KR (1) | KR100589022B1 (pt) |
CN (1) | CN1163235C (pt) |
AU (2) | AUPO104396A0 (pt) |
BR (1) | BR9710376A (pt) |
CA (1) | CA2262863A1 (pt) |
NZ (1) | NZ333541A (pt) |
WO (1) | WO1998003572A1 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2271249C (en) | 1996-11-14 | 2010-07-20 | Biota Scientific Management Pty. Ltd. | Macromolecular neuraminidase-binding compounds |
FR2781485B1 (fr) | 1998-07-21 | 2003-08-08 | Denis Barritault | Polymeres biocompatibles leur procede de preparation et les compositions les contenant |
AUPP913999A0 (en) | 1999-03-12 | 1999-04-01 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
AUPR001000A0 (en) * | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
US20040220139A1 (en) * | 2003-04-29 | 2004-11-04 | Sceusa Nicholas A. | Inhibiting viral infections |
DE102005056592A1 (de) * | 2005-11-25 | 2007-05-31 | Basf Ag | Herstellung und Verwendung von hochfunktionellen, hoch-oder hyperverzweigten Polylysinen |
JP2011020993A (ja) | 2009-06-16 | 2011-02-03 | Sekisui Chem Co Ltd | Rnaウイルス感染阻止成形用組成物及びrnaウイルス感染阻止成形品 |
JP2011136977A (ja) * | 2009-06-16 | 2011-07-14 | Sekisui Chem Co Ltd | Rnaウイルス感染阻止塗料用組成物、rnaウイルス感染阻止塗料及びrnaウイルス感染阻止製品 |
US20130189754A1 (en) | 2011-09-12 | 2013-07-25 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
JP5480998B1 (ja) * | 2012-03-27 | 2014-04-23 | 積水化学工業株式会社 | 繊維加工用インフルエンザウイルス感染阻止剤、これを用いた繊維製品及びその製造方法 |
US9347065B2 (en) | 2012-03-29 | 2016-05-24 | International Aids Vaccine Initiative | Methods to improve vector expression and genetic stability |
RU2673342C2 (ru) | 2013-02-19 | 2018-11-26 | Джонсон энд Джонсон Консьюмер Инк. | Способы и композиции для улучшения внешнего вида и формирования рубцовой ткани |
CA2955406A1 (en) | 2014-07-29 | 2016-02-04 | Uniwersytet Jagiellonski | Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hmpv), human rhinoviruses (hrv), and infection by influenza virus type a (iav) and pharmaceutical composition comprising the... |
CN116056714A (zh) * | 2020-04-15 | 2023-05-02 | 星法马有限公司 | 预防冠状病毒及/或呼吸道融合病毒感染的方法 |
GB202007701D0 (en) | 2020-05-22 | 2020-07-08 | Univ Manchester | Antiviral polymers |
CN114053394B (zh) * | 2020-07-30 | 2024-06-21 | 广州朗圣药业有限公司 | 新型化合物在制备预防和/或治疗冠状病毒感染的药物中的应用 |
TWI836258B (zh) * | 2020-08-21 | 2024-03-21 | 澳大利亞商星法馬私人有限公司 | 預防冠狀病毒及/或呼吸道融合病毒感染的方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2182667B1 (pt) * | 1972-05-03 | 1978-03-03 | Rhone Poulenc Ind | |
HU187669B (en) * | 1982-03-31 | 1986-02-28 | Richter Gedeon Vegyeszet | Process for producing new copolymeres and salts |
JPS632901A (ja) * | 1986-06-24 | 1988-01-07 | Chisso Corp | 植物ウイルス病防除剤 |
NL8900442A (nl) * | 1989-02-22 | 1990-09-17 | Stichting Rega V Z W | Gesulfateerde vinylpolymeren in geneesmiddelen voor het behandelen van retrovirus-infecties. |
JP2909500B2 (ja) * | 1989-03-23 | 1999-06-23 | ベルレックス、ラボラトリーズ、レンコーポレイテッド | 水溶性抗高脂質血症剤として有用な官能化側鎖を有するポリアミド |
FR2669535A1 (fr) * | 1990-11-26 | 1992-05-29 | Medgenix Group Sa | Utilisation a titre de medicament de macromolecules polysulfonees. |
US5869457A (en) | 1991-03-11 | 1999-02-09 | Rijksuniversiteit Te Groningen | Modified proteins and their use for controlling viral infections |
DE69326231T2 (de) * | 1992-01-14 | 1999-12-30 | Hisamitsu Pharmaceutical Co., Inc. | Cholesterinspiegelsenkendes mittel |
AUPM623994A0 (en) * | 1994-06-15 | 1994-07-07 | Biomolecular Research Institute Limited | Antiviral dendrimers |
FR2727117A1 (fr) | 1994-11-18 | 1996-05-24 | Geffard Michel | Utilisation de conjugues de la polylysine pour la preparation de medicaments utiles dans le traitement des maladies neurodegeneratives et des affections degeneratives a caractere autoimmun |
US6034129A (en) | 1996-06-24 | 2000-03-07 | Geltex Pharmaceuticals, Inc. | Ionic polymers as anti-infective agents |
US6007803A (en) | 1997-09-19 | 1999-12-28 | Geltex Pharmaceuticals, Inc. | Ionic polymers as toxin binding agents |
US6060235A (en) | 1997-09-19 | 2000-05-09 | Geltex Pharmaceuticals, Inc. | Antiviral polymers comprising acid functional groups and hydrophobic groups |
-
1996
- 1996-07-17 AU AUPO1043A patent/AUPO104396A0/en not_active Abandoned
-
1997
- 1997-07-17 BR BR9710376A patent/BR9710376A/pt not_active Application Discontinuation
- 1997-07-17 NZ NZ333541A patent/NZ333541A/xx unknown
- 1997-07-17 JP JP10506371A patent/JP2000516971A/ja active Pending
- 1997-07-17 AU AU33301/97A patent/AU730899B2/en not_active Ceased
- 1997-07-17 KR KR1019997000234A patent/KR100589022B1/ko not_active IP Right Cessation
- 1997-07-17 WO PCT/AU1997/000446 patent/WO1998003572A1/en not_active Application Discontinuation
- 1997-07-17 EP EP97929037A patent/EP0928306A4/en not_active Withdrawn
- 1997-07-17 CN CNB971964378A patent/CN1163235C/zh not_active Expired - Fee Related
- 1997-07-17 CA CA002262863A patent/CA2262863A1/en not_active Abandoned
-
2001
- 2001-08-15 US US09/929,014 patent/US6740635B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR20000067865A (ko) | 2000-11-25 |
JP2000516971A (ja) | 2000-12-19 |
US6740635B2 (en) | 2004-05-25 |
US20020025919A1 (en) | 2002-02-28 |
AU730899B2 (en) | 2001-03-15 |
CN1225653A (zh) | 1999-08-11 |
CN1163235C (zh) | 2004-08-25 |
EP0928306A4 (en) | 2003-04-16 |
EP0928306A1 (en) | 1999-07-14 |
NZ333541A (en) | 2000-09-29 |
WO1998003572A1 (en) | 1998-01-29 |
CA2262863A1 (en) | 1998-01-29 |
AU3330197A (en) | 1998-02-10 |
AUPO104396A0 (en) | 1996-08-08 |
KR100589022B1 (ko) | 2006-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9612204A (pt) | Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor | |
BR9710376A (pt) | Composto antiviral uso do mesmo composi-Æo farmac-utica e processo para tratamento antiviral profil tico ou terap-utico de um animal humano ou nÆo humano | |
BG95935A (bg) | Метод и средство за приемане на дексмедетомидин директно през кожата | |
BR9408148A (pt) | Processo para tratamento de arritmia composto e formulação farmacêutica | |
BR9610248A (pt) | Composto composição farmacêutica processos para o tratamento da dor e para a preparação de um composto e uso do composto | |
BR9609532A (pt) | Composição antimicrobiana para o tratamento de cabelo processo para o tratamento de caspa e uso da composição | |
HUP9904361A3 (en) | Use of isobutylgaba and its derivatives for the treatment of pain | |
BR9503812A (pt) | Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto | |
BR9508886A (pt) | Compostos e métodos para o tratamento de câncer | |
BR9711530A (pt) | Combina-Æo de terapia para tratamento de psicoses | |
DK0918505T3 (da) | Hudtoningsformulering | |
BR9702147A (pt) | Composição farmacéutica uso de uma composição farmacéutica e processo para o tratamento da dor associada com escarificação periodontal e para a preparação de uma composição farmacéutica | |
FI971969A0 (fi) | Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä | |
BR9709915A (pt) | Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto | |
DE69524138D1 (de) | Hautbehandlungsmittel | |
BR9505610A (pt) | Composto composição farmacéutica processo para a preparação de um composto uso e método de tratar inflamação e dor | |
BR9502471A (pt) | Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica | |
BR9708607A (pt) | Composto composição farmacéutica utilização de um composto processo para tratamento ou redução do risco de doença inflamatória num paciente e para a preparação de um composto e intermediário químico | |
BR9506581A (pt) | Composto composição farmacêutica uso do composto processo para a profilaxia ou tratamento de uma condição clínica em um manífero por exemplo um humano e para a preparação de um composto e composto intermediário | |
BR9610733A (pt) | Composto processos para a preparação do mesmo e para o tratamento de um mamífero composição farmacêutica e utilização de um composto | |
IL129144A0 (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin diseases | |
BR9611234A (pt) | Composto formulação farmacêutica uso do composto e processos para tratamento de uma dor e para a preparação de compostos | |
BR9510015A (pt) | Composto composição farmacéutica e processo para o tratamento de doenças enfecciosas em terapia humana ou veterinária | |
BR9612206A (pt) | Composto uso do composto composição farmacêutica processo para preparação do composto e para o tratamento da dor | |
BR9709930A (pt) | Composto composição farmacêutica uso de um composto e processos para tratamento de um indivíduo humano ou animal e para preparação de um composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |